Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-18-000499)

Filing Details

Accession Number:: 0001415889-18-000499
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-04-02 16:39:53
Reporting Period:: 2018-03-29

Accepted Time:: 2018-04-02 16:39:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1386570	Chromadex Corp.	CDXC	Medicinal Chemicals & Botanical Products (2833)	262940963

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1437237	Jr L Frank Jaksch	10005 Muirlands Blvd. Suite G Irvine CA 92618	Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-29	474	$4.50	202,031	No	4	M	Direct
Common Stock	Disposition	2018-03-29	474	$4.60	201,557	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Options (right to buy)	Disposition	2018-03-29	474	$0.00	474	$4.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
171,503	2009-04-21	2018-04-21	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,075,052	Indirect	By Black Sheep, FLP

Footnotes

Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on March 16, 2018. The options exercised and sold were scheduled to expire on April 21, 2018.